Organon (OGN) Company Total Revenue

Corporate emblem and logo of Organon (OGN)

Organon & Co. (OGN) aims for leadership in reproductive medicine through biosimilar expansion and the acquisition of biotech firms. However, post-spin-off debt and the risk of patent expiration are creating pressure. The company's trading revenue dynamics illustrate operational cycles, where 6.10 reflects the metric's baseline. Business stability relies on implant sales, while management strictly controls the credit load.

Organon Corp (OGN) - Revenue and Sales Volume from 07/04/2022 to 11/13/2026

Analytical breakdowns for Organon & Co.

- current price and projected stock value:
Share Price Organon Pharma|OGN - Price Target Chart
- market capitalization details:
Market Value Organon & Co.|OGN - Total Company Value
- book value of equity indicators:
Accounting Value of a Share Organon|OGN - Book Capitalization|Market Value to Equity Ratio organon.com|OGN - Company Total Assets
- company liabilities and liquidity data:
Total Debt to Capital Organon & Co.|OGN - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio Organon & Co|OGN - Company Debts|Debts to Book Value Organon & Co.|OGN - Company Long-Term Debt|Company Short-Term Indebtedness Organon|Intermediate Coverage Ratio organon.com
- earnings and valuation multiples indicators:
OGN - Company Profit|Future Net Profit Organon & Co.|OGN - Price to Earnings Ratio|Future Price to Earnings Multiple organon.com|OGN - PEG Multiple|Enterprise Value to EBITDA Ratio Organon & Co.|OGN - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Organon|OGN - Net earnings per share for the last 12 months|Year-over-year net earnings per share change for the last twelve months organon.com|OGN - Earnings per share growth in current year|Expected net earnings per share growth next year Organon & Co.
- company sales and revenue statistics:
OGN - Revenue and Sales Volume|Company Sales Forecast Organon Pharma|OGN - Price-to-Revenue Ratio|Market Cap to Projected Revenue Organon & Co.
Comprehensive company analysis:OGN (Organon Pharma)
Core merchandise of Organon Pharma

This indicator measures the aggregate cash flow from product sales, reflecting the business's fundamental ability to generate revenue and its market resilience. By analyzing the absolute sales of Organon & Co. (OGN), an investor can see the impact of implementing robotic lines and AI platforms, which optimize the production of women's health medications by reducing manual labor costs and minimizing manufacturing defects.

Analysis of competing companies

Company Sales Volume DARE (Daré Bioscience, Inc.)|Company Revenue TherapeuticsMD, Inc. (TXMD)|PTN - Company Total Revenue